BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 11012213)

  • 1. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
    Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
    Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of thrombopoietin and its therapeutic potential.
    Miyazaki H
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S74-7. PubMed ID: 8765422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
    Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
    Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
    Akahori H; Shibuya K; Ozai M; Ida M; Kabaya K; Kato T; Miyazaki H
    Stem Cells; 1996 Nov; 14(6):678-89. PubMed ID: 8948025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of recombinant interleukin 11 in megakaryocytopoiesis.
    Turner KJ; Neben S; Weich N; Schaub RG; Goldman SJ
    Stem Cells; 1996; 14 Suppl 1():53-61. PubMed ID: 11012203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
    Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
    Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchical structure of human megakaryocyte progenitor cells.
    Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E
    Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro expansion of cord blood megakaryocyte progenitor].
    Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin from human embryonic kidney cells stimulates an increase in megakaryocyte size of sublethally irradiated mice.
    Carter CD; Schultz TW; McDonald TP
    Radiat Res; 1993 Jul; 135(1):32-9. PubMed ID: 8327658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of megakaryopoiesis induced by recombinant human interleukin 11 in myelosuppressed mice.
    Saitoh M; Taguchi K; Momose K; Suga K; Ogawa Y; Yasuda S; Miyata K
    Cytokine; 2001 Mar; 13(5):287-94. PubMed ID: 11243707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.